In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
12 Setembro 2023 - 9:56AM
Neuronetics, Inc. (NASDAQ: STIM), a medical technology company
focused on designing, developing, and marketing products that
improve the quality of life for patients who suffer from
neurohealth disorders, in recognition of National Suicide
Prevention Awareness Month, announced the launch of the NeuroStar
Voices Portal, a platform aimed at fostering connections, sharing
stories of possibility, and building a supportive community for
individuals battling depression. To illustrate the types of
experiences people may share through the portal, Neuronetics is
highlighting Damon Devine, a NeuroStar patient who broke the cycle
of multiple suicides among the men in his family.
“Depression can be isolating, and we want people suffering from
it to realize they are not alone. The NeuroStar Voices Portal
allows us to share real-world examples of how depression affects
people, along with the positive impact that NeuroStar has had on
their lives,” commented Lisa Metzner-Rosas, Senior Vice President,
Chief Marketing Officer, Neuronetics Inc. “Our patient advocates
have helped us to bring the patient voice to the center of
everything we are doing. We are touched by Damon’s courage in
publicly sharing his experience so that it may bring hope to
others.”
At the core of the portal is a network of real patients who have
experienced successful treatment for depression and can serve as
ambassadors through NeuroStar’s “Tap Into Possibility” campaign.
These ambassadors will share their own stories and connect with
potential patients to increase awareness around NeuroStar treatment
and foster a sense of community.
“When NeuroStar worked, I couldn't believe it. In my family, I'm
the only male left. There is a hereditary component to suicide, as
almost all the male members of my family did not live past 55 years
old. The suicidal thoughts, which were commonplace for me, were the
first thing to go,” stated patient Damon Devine. “Coming out of
depression felt like being let out of prison. It was freedom after
being imprisoned even though I’d done nothing wrong.”
Damon’s story is just one of the patient stories highlighted as
part of this campaign. Damon battled deep depression for decades
since childhood amid a dark family history of suicides. The
constant facade of being "fine" exhausted him. After failed
attempts with antidepressants, he considered giving up. Yet, he
decided to try one last option: NeuroStar Advanced Therapy. Within
weeks, he underwent a remarkable transformation. He vividly noticed
the beauty of everyday things and started to connect with people
again. During Suicide Prevention Month and beyond, individuals
enduring the difficulties of depression will find solace in stories
of resilience and recovery, like Damon's. These stories not only
inspire those seeking solutions for their depression but also serve
as a powerful reminder that surrendering is not the answer.
The stories of NeuroStar ambassadors will be amplified through
strategic efforts across social, digital, and earned media. For
more information about NeuroStar TMS Therapy, please visit
NeuroStar.com.
About NeuroneticsNeuronetics,
Inc. believes that mental health is as important as physical
health. As a global leader in
neuroscience, Neuronetics is redefining patient and
physician expectations with its NeuroStar Advanced Therapy for
Mental Health. NeuroStar is a non-drug, noninvasive treatment that
can improve the quality of life for people suffering from
neurohealth conditions when traditional medication hasn’t helped.
NeuroStar is FDA-cleared for adults with major depressive disorder
(MDD), as an adjunct for adults with obsessive-compulsive disorder
(OCD), and to decrease anxiety symptoms in adult patients with MDD
that may exhibit comorbid anxiety symptoms (anxious depression).
NeuroStar Advanced Therapy is the leading transcranial magnetic
stimulation (TMS) treatment for MDD in adults with over 5.6 million
treatments delivered. NeuroStar is backed by the largest clinical
data set of any TMS system for depression, including the world’s
largest depression Outcomes Registry. Neuronetics is
committed to transforming lives by offering an exceptional
treatment that produces extraordinary results. For safety and
prescribing
information, www.neurostar.com.
Media
Contact:EvolveMKD646.517.4220NeuroStar@evolvemkd.com
Neuronetics (NASDAQ:STIM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Neuronetics (NASDAQ:STIM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024